Generic Brand Classification Mechanism of Indication Contraindication Side effects How Dosage & Nursing responsibilities

name name action supplied frequency

Biperiden Akineton Cholinergic Biperiden is a >As an adjunct in >Hypersensitivity dry mouth; blurred Injection: >Instruct patients to take
HCl blocking drug, tertiary amine the therapy of all to biperiden vision; 5mg/ml medication after meals
Antiparkinson antimuscarinic forms > Narrow angle drowsiness;euphoria or (as to avoid gastric irritation.
drug with central and of parkinsonism glaucoma disorientation; urinary r lactate) Do not stop abruptly.
peripheral action (idiopathic, > Bowel etention; postural Tablets: >do not use with
s. It stimulates postencephalitic, obstruction hypotension; constipati 2mg antacids or antidiarrheal
and then arteriosclerotic) >Megacolon on; agitation; disturbed for 1-2 hours after taking
depresses the >Control of >Children under behavior may been drug.
CNS, it also has extrapyramidal 3 years of age. seen. A case of >in IV administration,
antispasmodic a disorders generalized choreic position client in a
ctions on smooth secondary movements has been recumbent position.
muscle and to neuroleptic dru reported in >Instruct patient to
reduces g therapy (e.g., a Parkinson's record stools; increase
secretions, esp phenothiazines) disease patient when intake of fluids, fruit
salivary and biperiden was added to juices and fiber to avoid
bronchial carbidopa/levodopa. A constipation: report
secretions reduction in rapid eye urinary difficulty.
movement (REM) >teach patient to avoid
sleep, characterized by activities that would
increased REM latency require mental alertness
and decreased until drug effects
percentage ofREM realized. May cause
sleep, has been dizziness, drowsiness,
reported. There usually or blurred vision.
are no significant
changes in blood
pressure or heart
rate in patients who
have been given the
parenteral form of
AKINETON. Mild
transient postural hypot
ension and bradycardia
may occur. These side
effects can be
minimized or avoided
by slow intravenous
administration. No local
tissue reactions have
been reported following
intramuscular injection.
If gastric irritation
occurs following oral
administration, it can
be avoided by
administering the drug
during or after meals.